Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04912_nanopub.RAo2u-NrYhM8c8RotXZTl_kMMdTiv7mzUkgdP4FxuYD-o#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04912 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04912 label "Stannsoporfin [drugbank:DB04912]" assertion.
- drugbank:DB04912 seeAlso DB04912 assertion.
- drugbank:DB04912 identifier "drugbank:DB04912" assertion.
- drugbank:DB04912 description "Stannsoporfin is a competitive heme oxygenase (HO) inhibitor being developed by InfaCare, a subsidiary of WellSpring Pharmaceuticals, for the prevention of hyperbilirubinemia in infants at risk of developing jaundice." assertion.
- drugbank:DB04912 title "Stannsoporfin" assertion.
- drugbank:DB04912 bio2rdf_vocabulary:identifier "DB04912" assertion.
- drugbank:DB04912 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04912 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04912" assertion.
- drugbank:DB04912 bio2rdf_vocabulary:x-identifiers.org DB04912 assertion.
- drugbank:DB04912 drugbank_vocabulary:drugbank-id "DB04912" assertion.
- drugbank:DB04912 drugbank_vocabulary:x-cas cas:106344-20-1 assertion.